Summary

MaxCyte, Inc. (MaxCyte) is a biotherapeutics company. The company offers cell-based therapies for chronic and acute diseases. It offers products such as MaxCyte STX, MaxCyte VLX and MaxCyte GT. The company offers services such as transfection insourcing services, processing assemblies and quality systems. MaxCyte’s drug delivery application includes GPCR’s, Ion channels, primary cell transfusion and maxcyte STX instrument. Its protein protection includes antibody protection, general protein production, viral vector and VLP production, and insect cell transfectionMaxCyte is headquartered in Gaithersburg, Maryland, the US.

MaxCyte, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2


MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 5
MaxCyte, Inc., Pharmaceuticals and Healthcare Deals By Type, 2008 to YTD 2014 6
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2008 to YTD 2014 7
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2008 to YTD 2014 8
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deal Details 9
Licensing Agreements 9
MaxCyte Expands Licensing Agreement With Medinet 9
Asset Transactions 10
Paragon Bioservices Acquires MaxCyte VLX Large Scale Transfection System And MaxCyte STX Scalable Transfection System From MaxCyte 10
CCS Cell Culture Service Acquires MaxCyte STX From MaxCyte 11
MaxCyte, Inc. - Key Competitors 12
Key Employees 13
Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables

MaxCyte, Inc., Pharmaceuticals and Healthcare, Key Facts 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2008 to YTD 2014 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 5
MaxCyte, Inc., Pharmaceuticals and Healthcare Deals By Type, 2008 to YTD 2014 6
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2008 to YTD 2014 7
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals Summary, 2008 to YTD 2014 8
MaxCyte Expands Licensing Agreement With Medinet 9
Paragon Bioservices Acquires MaxCyte VLX Large Scale Transfection System And MaxCyte STX Scalable Transfection System From MaxCyte 10
CCS Cell Culture Service Acquires MaxCyte STX From MaxCyte 11
MaxCyte, Inc., Key Competitors 12
MaxCyte, Inc., Key Employees 13

List of Figures

MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2008 to YTD 2014 1
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 5
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 6
MaxCyte, Inc., Pharmaceuticals and Healthcare, Deals By Region, 2008 to YTD 2014 7

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Degenerative Disc Disease - Pipeline Review, H1 2014

Degenerative Disc Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Degenerative Disc Disease - Pipeline Review, H1 2014', provides an overview of the Degenerative Disc Disease's therapeutic ...

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Critical Limb Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

Bone Regeneration - Pipeline Review, H2 2014

Bone Regeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.